Company intelligence / Profile preview

Worksite Labs

Long Beach, California, United States

Ownership: Private
Development stage: Other

Overview

Worksite Labs operated decentralized clinical laboratories and mobile diagnostic units (often built from repurposed shipping containers) that provided rapid COVID-19 testing and a broad menu (400+ assays) of blood and urine diagnostics across the western United States, New York, and Guam, but the company filed for Chapter 11 bankruptcy in July 2023 and its laboratory equipment was ordered to be sold at auction, indicating wind‑down of operations.[1][11]

Therapeutic areas: HematologyImmunologyOtherInfectious Diseases
Modalities: Diagnostic test
Industry: Molecular Diagnostics

Partnerships

Statera Biopharma (non‑consummated: letter of intent for merger in 2023)[9]

Beyond the preview

Go deeper on Worksite Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Worksite Labs.

Explore the full profile